<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1174</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2019-12-24-26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Contract manufacturing and R&amp;D: emerging trends for the global pharmaceutical market</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Prozherina</surname><given-names>Yu.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2019-12-12" publication-format="electronic"><day>12</day><month>12</month><year>2019</year></pub-date><issue>12</issue><fpage>24</fpage><lpage>26</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2019,</copyright-statement><copyright-year>2019</copyright-year></permissions><abstract>In recent years, health expenditures  have been gradually increasing. The expenditures  under this article in 60 countries  are expected to grow at an average of 5.4 percent during the period from 2018 to 2024 [1]. The key trends include the focus on RD development with a reasonable realignment of budget and the increasing contract manufacturing practice.</abstract><kwd-group xml:lang="en"><kwd>R&amp;D</kwd><kwd>pharmaceutical market</kwd><kwd>contract manufacturing</kwd><kwd>R&amp;D</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фармацевтический рынок</kwd><kwd>контрактное производство</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Deloitte. 2019 Global life sciences outlook. Focus and transform. Accelerating change in life sciences. Source: https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-ls-outlook-2019.pdf.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>EvaluatePharma®. World Preview 2019, Outlook to 2024. Source: https://info.evaluate.com/rs/607-YGS-364/images/EvaluatePharma_World_Preview_2019.pdf.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Global Pharmaceutical Contract. Mordor Intelligence. Source: https://www.mordorintelligence.com/industry-reports/global-pharmaceutical-contract-manufacturing-market-industry.</mixed-citation></ref></ref-list></back></article>
